Edition:
United States

Profile: Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

155.00EUR
23 Sep 2016
Change (% chg)

-- (--)
Prev Close
€155.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,189
52-wk High
€223.80
52-wk Low
€144.10

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.

Company Address

Virbac SA

13eme rue LID, BP 27
CARROS     06510
P: +334.92087100
F: +334.92087165

Company Web Links